MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer.
about
Recent developments in colorectal imagingAssessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving TreatmentMRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancerMITHRA - multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: a feasibility study.Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma.Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer.Whole-body PET/MRI for colorectal cancer staging: Is it the way forward?MR imaging perfusion and diffusion analysis to assess preoperative Short Course Radiotherapy response in locally advanced rectal cancer: Standardized Index of Shape by DCE-MRI and intravoxel incoherent motion-derived parameters by DW-MRI.SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.2D radially compensating excitation pulse in combination with an internal transceiver antenna for 3D MRI of the rectum at 7 T.Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival.Radiomic analysis in T2W and SPAIR T2W MRI: predict treatment response to chemoradiotherapy in esophageal squamous cell carcinoma.Impact of Perineural and Lymphovascular Invasion on Oncological Outcomes in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Surgery
P2860
Q34782793-650CB66A-5897-46CF-85D5-75C3F44E24B5Q36128038-3D3CA878-C4CC-477B-AFE2-C0AD1FDB01DDQ36235746-10A526E0-32D4-4203-B459-56DE2C708720Q36328596-9061FA93-082A-4644-861A-805B906712C4Q37190172-E9E687E6-9D92-43E3-8B53-5A692BF7AE31Q37226129-6CF5106C-DC50-4BB9-A68B-4FA9AC8733F9Q37702677-55F59689-A791-47D3-91F4-C0B6B497EF1BQ38641099-EF1494F5-9D08-4103-AB50-C09F8532878BQ38877730-30D94DFB-2575-463A-9AF3-D5CD6BEECA29Q47335954-29699A72-F188-4FA9-8AE3-9D708C59A595Q47744121-3A3DBD87-4D7F-4F10-A9F7-5192837C6E3CQ50617882-BC7EC802-5DC5-4B30-A8BD-CC025615E0B6Q52874057-1E40776C-DF44-4DC2-9BDA-A10F61016431Q55036808-FAAE42CE-6B7E-43AD-B889-C59784AAD231Q58283293-919AE83D-660A-41DB-B513-31ABE5E9FB4B
P2860
MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer.
@en
type
label
MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer.
@en
prefLabel
MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer.
@en
P2860
P356
P1476
MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer
@en
P2093
Regina G H Beets-Tan
P2860
P2888
P304
P356
10.1038/NRGASTRO.2014.41
P407
P577
2014-03-25T00:00:00Z